MTOR and cancer: Notably, inhibition of mTOR reduces the expression of programmed cell death–ligand protein 1 (PD-L1), which is known to confer cancer cells with the ability of immune evasion (19, 20); thus, the molecular basis of the dysregulation of the mTOR/autophagy pathway in breast cancer development requires further elucidation.